The FF bladder signature conservation set - samples
收藏NIAID Data Ecosystem2026-03-10 收录
官方服务：
资源简介：
Description not providedEGA dataset EGAD00001000833
应用场景：
创建时间：
2017-07-26
相关数据集
Subtype classification, grading, and outcome prediction of urothelial carcinomas by combined mRNA profiling and aCGH
[original title] Combined gene expression and genomic profiling define two intrinsic molecular subtypes of urothelial carcinoma and gene signatures for molecular grading and outcome. In the present i
NIAID Data Ecosystem140
Supplementary Data from Molecular Characterization of Neuroendocrine-like Bladder Cancer
Supplemental Tables
NIAID Data Ecosystem60
Dysregulation of EMT Drives the Progression to Clinically Aggressive Sarcomatoid Bladder Cancer [RT-PCR]
The progression of conventional urothelial carcinoma (UC) of the bladder to a tumor with a mesenchymal phenotype, referred to as sarcomatoid carcinoma (SARC), is signified by a high propensity for reg
NIAID Data Ecosystem30
Molecular subtyping of “double negative” MIBC
Identifying patients that benefit from cisplatin-based adjuvant chemotherapy is a major issue in the management of muscle-invasive bladder cancer (MIBC). The purpose of this study is to correlate “lum
NIAID Data Ecosystem80
Identification of Differential Tumor Subtypes of T1 Bladder Cancer
Stage T1 bladder cancers have the highest progression and recurrence rates of all non-muscle invasive bladder tumors. T1 tumors are heterogeneous; while most T1 patients are treated with BCG, many wil
NIAID Data Ecosystem60
